Anaphylaxis in pediatric patients: single-center study in a private hospital
Main Article Content
Keywords
adrenaline, anaphylaxis, children, food allergy, incidence
Abstract
This study aimed to characterize the profile of probable anaphylaxis cases treated at a private pediatric hospital emergency department in São Paulo. It investigated triggering factors, the presence of cofactors, treatments administered, and follow-up for these cases through interviews with the patients’ families. A single-center cross-sectional study analyzed medical records of children and adolescents treated between 2016 and 2020. Allergist physicians evaluated cases with symptoms consistent with anaphylaxis to identify probable cases, and the parents or legal guardians of these cases were interviewed to gather detailed information about the episodes. A total of 69 probable cases of anaphylaxis (PCA) were identified among 460,434 visits. Of the 51 PCAs evaluated, most presented with cutaneous and respiratory symptoms, with a male predominance (63%), and 27% were under 2 years old. Foods, particularly nuts and peanuts, were the primary triggers. Nearly one-third of the patients did not undergo investigation following the episode, and intramuscular adrenaline (37%) and auto-injectable adrenaline (4%) were underutilized as treatments. Eight cases exhibited recurrence of symptoms after initial improvement, suggesting a potential biphasic reaction. In conclusion, this study revealed that the majority of PCAs occurred in male children, with nuts and peanuts as the main triggers. The management of PCAs was suboptimal, characterized by the underutilization of intramuscular adrenaline as the first-line treatment and low rates of auto-injectable adrenaline prescriptions during follow-up. Increasing awareness and education about anaphylaxis in children, along with emphasizing the importance of proper treatment, are crucial to reducing the risk of morbidity and mortality in this vulnerable population.
References
2 Simons FER, Ardusso LRF, Bilò MB, El-Gamal YM, Ledford DK, Ring J, et al. World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis. World Allergy Organ J. 2011;4(2):13–37. 10.1097/WOX.0b013e318211496c
3 Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391–7. 10.1016/j.jaci.2005.12.1303
4 Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992;327(6):380–4. 10.1056/NEJM199208063270603
5 Umasunthar T, Leonardi-Bee J, Turner PJ, Hodes M, Gore C, Warner JO, et al. Incidence of food anaphylaxis in people with food allergy: a systematic review and meta-analysis. Clin Exp Allergy. 2015;45(11):1621–36. 10.1111/cea.12477
6 Tanno LK, Demoly P. Anaphylaxis in children. Marseglia GL, organizer. Pediatr Allergy Immunol. 2020;31(S26):8–10. 10.1111/pai.13336
7 Nunes FA, Zanini F, Braga CDS, Da Silva AL, Fernandes FR, Solé D, et al. Incidence, triggering factors, symptoms, and treatment of anaphylaxis in a pediatric hospital. World Allergy Organ J. 2022;15(9):100689. 10.1016/j.waojou.2022.100689
8 P. Goddu A, O’Conor KJ, Lanzkron S, Saheed MO, Saha S, Peek ME, et al. Do words matter? Stigmatizing language and the transmission of bias in the medical record. J Gen Intern Med. 2018;33(5):685–91. 10.1007/s11606-017-4289-2
9 Tanno LK, Ganem F, Demoly P, Toscano CM, Bierrenbach AL. Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10. Allergy.2012;67(6):783–9. 10.1111/j.1398-9995.2012.02829.x
10 Reber LL, Hernandez JD, Galli SJ. The pathophysiology of anaphylaxis. J Allergy Clin Immunol. 2017;140(2):335–48. 10.1016/j.jaci.2017.06.003
11 De Filippo M, Votto M, Albini M, Castagnoli R, De Amici M, Marseglia A, et al. Pediatric anaphylaxis: A 20-year retrospective analysis. J Clin Med. 2022;11(18):5285. 10.3390/jcm11185285
12 Järvinen KM. Food-induced anaphylaxis. Curr Opin Allergy Clin Immunol. 2011;11(3):255–61. 10.1097/ACI.0b013e32834694d8
13 Grabenhenrich LB, Dölle S, Moneret-Vautrin A, et al. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol. 2016;137(4):1128-1137.e1. 10.1016/j.jaci.2015.11.015
14 Jackson KD, Howie LD, Akinbami LJ. Trends in allergic conditions among children: United States, 1997-2011. NCHS Data Brief. 2013;(121):1-8.
15 Adams KE, Tracy JM, Golden DBK. Anaphylaxis to stinging insect venom. Immunol Allergy Clin North Am. 2022;42(1):161–73. 10.1016/j.iac.2021.09.003
16 Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol. 2005;5(4):359–64. 10.1097/01.all.0000174158.78626.35
17 Yocum MW, Butterfield JH, Klein JS, Volcheck GW, Schroeder DR, Silverstein MD. Epidemiology of anaphylaxis in Olmsted County: A population-based study. J Allergy Clin Immunol. 1999;104(2):452–6. 10.1016/s0091-6749(99)70392-1
18 Peng MM, Jick H. A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Arch Intern Med. 2004;164. 10.1001/archinte.164.3.317
19 Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K, Bindslev-Jensen C, et al. EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy. Allergy. 2014;69(8):1008–25. 10.1111/all.12429
20 Muraro A, De Silva D, Halken S, Worm M, Khaleva E, Arasi S, et al. Managing food allergy: GA2LEN guideline 2022. World Allergy Organ J. 2022;15(9):100687. 10.1016/j.waojou.2022.100687
21 Feketea G, Tsabouri S. Common food colorants and allergic reactions in children: Myth or reality? Food Chem. 2017;230:578–88. 10.1016/j.foodchem.2017.03.043
22 Fuglsang G, Madsen C, Saval P, Osterballe O. Prevalence of intolerance to food additives among Danish school children. Pediatr Allergy Immunol. 1993;4(3):123–9. 10.1111/j.1399-3038.1993.tb00080.x
23 Fuglsang G, Madsen C, Halken S, Jorgensen M, Ostergaard PA, Osterballe O. Adverse reactions to food additives in children with atopic symptoms. Allergy. 1994;49(1):31–7. 10.1111/j.1398-9995.1994.tb00770.x
24 Tejedor-Alonso MA, Moro-Moro M, Múgica-García MV. Epidemiology of anaphylaxis: contributions from the last 10 years. J Investig Allergol Clin Immunol. 2015;25(3):163–175.
25 Pouessel G, Antoine M, Pierache A, Dubos F, Lejeune S, Deschildre A, et al. Factors associated with the underuse of epinephrine in children with anaphylaxis. Clin Exp Allergy. 2021;51(5):726–9. 10.1111/cea.13821
26 Prince BT, Mikhail I, Stukus DR. Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities. J Asthma Allergy. 2018;11:143–51. 10.2147/JAA.S159400
27 Tanno LK, Molinari N, Annesi-Maesano I, Demoly P, Bierrenbach AL. Anaphylaxis in Brazil between 2011 and 2019. Clin Exp Allergy. 2022;52(9):1071–8. 10.1111/cea.14193
28 Lee S, Sadosty AT, Campbell RL. Update on biphasic anaphylaxis. Curr Opin Allergy Clin Immunol. 2016;16(4):346–51. 10.1097/ACI.0000000000000279
29 Pourmand A, Robinson C, Syed W, Mazer-Amirshahi M. Biphasic anaphylaxis: A review of the literature and implications for emergency management. Am J Emerg Med. 2018;36(8):1480–5. 10.1016/j.ajem.2018.05.009
